Canada | 001-14956 | 98-0448205 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
7150 Mississauga Road Mississauga, Ontario Canada |
L5N 8M5 | |
(Address of principal executive offices) | (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 | Other Events. |
Item 9.01 | Financial Statements and Exhibits. |
Exhibit | ||||
Number | Description | |||
99.1 | Press Release announcing the pricing of the offering, dated February 3, 2011 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC., |
|||||
By: | /s/ Robert Chai-Onn | ||||
Name: | Robert Chai-Onn | ||||
Title: | Executive Vice President, General Counsel and Corporate Secretary | ||||
Exhibit | ||||
Number | Description | |||
99.1 | Press Release announcing the pricing of the offering, dated February 3, 2011 |